Accelerate cell & gene therapy success with cGMP gene editing components and regulatory compliance

The manufacturing of gene editing (GE) components is a pivotal aspect of GE-based Cell and Gene Therapy development, requiring meticulous attention to product quality and regulatory compliance throughout the development lifecycle. In this webinar, we will discuss the key differences between GE components used from early discovery through to clinical application, and provide insight into how phase-appropriate components can be used to achieve clinical objectives while balancing quality and cost.